Global X China Biotech ETF

254900A5Q8X7WAP62Y74

The entity

Status: Active
LEI status: Issued and current
Category: Fund
Legal form: 8888
Jurisdiction: Hong Kong SAR China
Entity created: July 23, 2019

Address

Country: Hong Kong SAR China
Legal address: Room 1101, 11/F, Lee Garden Three, 1 Sunning Road, Causeway Bay999077 Hong KongHong Kong SAR China
Head office: C/O Mirae Asset Global Investments (Hong Kong) Limited, Room 1101, 11/F, Lee Garden Three, 1 Sunning Road999077 Hong KongHong Kong SAR China

Identifier

LEI: 254900A5Q8X7WAP62Y74
Registered: May 12, 2021 at 12:16 PM UTC
Last updated: February 4, 2026 at 12:50 PM UTC
Next renewal: February 12, 2027 at 12:16 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Securities and Futures Commission (RA000390)
Identifier: BOJ917
Verified against: Securities and Futures Commission (RA000390)
Verified as: BOJ917
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owned by

未來資產環球投資(香港)有限公司
Fund managerHong Kong SAR China549300NL7HTCLIXMWU28
Global X ETF Series
Umbrella fundHong Kong SAR China254900D834P0D68A2K22

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/254900A5Q8X7WAP62Y74This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search